Overview
Stroke care is evolving rapidly and staying current has never been more critical. From extended-window thrombolysis and new guideline updates to emerging therapies in recovery and secondary prevention, today’s clinicians face both new challenges and unprecedented opportunities to improve patient outcomes.
This dynamic symposium delivers the latest advancements across the full stroke care continuum, spanning acute management, complex patient populations, rehabilitation, and long-term prevention. With expert-led sessions, real-world case discussions, and a powerful keynote on reducing disparities, the program is
designed to provide practical insights you can apply immediately in clinical practice.
Attendees will explore cutting-edge treatment strategies, refine decision-making in high-stakes scenarios, and gain a deeper understanding of multidisciplinary approaches that support recovery and reduce readmissions. Whether in the ED, ICU, clinic, or rehab setting, this symposium equips you with the tools to deliver more timely, effective, and patient-centered stroke care.
Target Audience
This educational activity is intended for neurologists, emergency medicine physicians, neurosurgeons, primary care physicians, residents, fellows, nurse practitioners, nurses, physician assistants, physical therapists, occupational therapists and allied health professionals.
Learning Objectives
After completing this educational activity, participants will be able to do the following:
- Describe the published evidence supporting extended window thrombolysis in acute stroke care and discuss its use in clinical practice.
- Summarize the clinical evidence supporting the revised AHA/ASA guidelines on acute ischemic stroke.
- Apply clinical guidelines for treating acute stroke to specific pediatric patient populations.
- Discuss the success and failure rates of clinical interventions aimed at reducing stroke recurrence and describe strategies to improve these outcomes.
- Summarize the clinical evidence supporting the recent AHA scientific statement for assessing and treating patients with cancer and stroke.
- Critically review the clinical trial evidence on the use of Factor XIa in secondary stroke prevention.
- Highlight key innovations in recent guidelines on lipoprotein testing and management and describe their optimal use in clinical practice.
- Define important disparities that exist in stroke care and appraise efforts to address those gaps.
- Describe best practices for recognition, diagnosis, and treatment of stroke cases in the emergency department and for stroke survivor care.